InvestorsHub Logo
Followers 825
Posts 119423
Boards Moderated 16
Alias Born 09/05/2002

Re: None

Tuesday, 10/17/2017 7:06:43 PM

Tuesday, October 17, 2017 7:06:43 PM

Post# of 3562
TEVA submits Fremanezumab (anti-CGRP) BLA for migraine prevention:

https://www.businesswire.com/news/home/20171017005667/en

“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent TEVA News